Pancreatic secretory trypsin inhibitor acts as an effective inhibitor of cysteine proteinases gingipains from Porphyromonas gingivalis

Journal of Periodontal Research

Volumn 43, Issue 2, 2008, Pages 232-236

  Bania, J ^a   Kubiak, A ^b   Wojtachnio, K ^b   Polanowski, A ^b  

^a WROCLAW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

^b UNIVERSITY OF WROC AW   (Poland)

Author keywords

Gingipain inhibitor; Gingipains; Kazal type trypsin inhibitor; Pancreas; Porphyromonas gingivalis

Indexed keywords

EID: 39749176517     PISSN: 00223484     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0765.2007.01020.x     Document Type: Article

References (27)

1. 1 Kazal LA, Spicer DS, Brahinsky RA. Isolation of a crystalline trypsin inhibitor‐anticoagulant protein from pancreas. J Am Chem Soc 1948 ; 70: 3034–3040.
2. 2 Shibata T, Ogawa M, Takata N et al. Distribution of pancreatic secretory trypsin inhibitor in various human tissues and its inactivation in the gastric mucosa. Res Commun Chem Pathol Pharmacol 1987 ; 55: 243–248.
3. 3 Marchbank T, Freeman TC, Playford RJ. Human pancreatic secretory trypsin inhibitor. Distribution, action and possible role in mucosal integrity and repair. Digestion 1998 ; 59: 167–174.
4. 4 Laskowski M, Kato I. Protein inhibitors of proteinases. Annu Rev Biochem 1980 ; 49: 593–626.
5. 5 Wilimowska‐Pelc A, Olichwier Z, Mazurkiewicz A, Kowalska J, Wilusz T. Kazal‐type chymotrypsin inhibitor from duck pancreas. Comp Biochem Physiol 2002 ; 131B: 499–507.
6. 6 Matsuda K, Ogawa M, Shibata T et al. Postoperative elevation of serum pancreatic secretory trypsin inhibitor. Am J Gastroenterol 1985 ; 80: 694–698.
7. 7 Ogawa M. Pancreatic secretory trypsin inhibitor as an acute phase reactant. Clin Biochem 1988 ; 21: 19–25.
8. 8 Tsuzuki S, Kokado Y, Satomi S et al. Purification and identification of a binding protein for pancreatic secretory trypsin inhibitor: a novel role of the inhibitor as an anti‐granzyme A. Biochem J 2003 ; 372: 227–233.
9. 9 Page RC. Critical issues in periodontal research. J Dent Res 1995 ; 74: 1118–1128.
10. 10 Travis J, Pike R, Imamura T, Potempa J. Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. J Periodont Res 1997 ; 32: 120–125.
11. 11 Chen Z, Potrempa J, Polanowski A, Wilkstrom M, Travis J. Purification and characterization of a 50‐kDa cysteine proteinase (gingipain) from Porphyromonas gingivalis. J Biol Chem 1992 ; 267: 18896–18901.
12. 12 Potempa J, Pike R, Travis J. Titration and mapping of the active site of cysteine proteinases from Porphyromonas gingivalis (gingipains) using peptidyl chloromethanes. Biol Chem 1997 ; 378: 223–230.
13. 13 Kuramitsu HK. Protease of porphyromonas gingivalis: what don't they do? Oral Microbiol Immunol 1998 ; 13: 263–270.
14. 14 Travis J, Potempa J. Bacterial proteinases as targets for the development of second‐generation antibiotics. Biochim Biophys Acta 2000 ; 1477: 35–50.
15. 15 Krauser JA, Potempa J, Travis J, Powers JC. Inhibition of Arginine Gingipains (RgpB and HrgpA) with benzamidine inhibitors: Zinc increases inhibitory potency. Biol Chem 2002 ; 383: 1193–1198.
16. 16 Okomoto M, Sugimoto A, Leung KP, Nakayama K, Kamaguchi A, Maeda N. Inhibitory effect of green tea catechins on cysteine proteinases in Porphyromonas gingivalis. Oral Microbiol Immunol 2003 ; 18: 1–3.
17. 17 Wilimowska‐Pelc A, Stachowiak DG, Ladysz M, Olichwier Z, Polanowski A. Antiproteolytic activity of goose pancreas: purification, inhibitory properties and amino acid sequence of Kazal‐type trypsin inhibitor. Acta Biochim Pol 1996 ; 43: 489–496.
18. 18 Smith PK, Krohn RI, Hermanson GT et al. Measurement of protein using bicinchoninic acid. Anal Biochem 1985 ; 150: 76–85.
19. 19 Chase T, Shaw E. Titration of trypsin, plasmin and thrombin with p‐nitrophenyl p‐guanidinobenzoate HCl. In: Colowic SP, Kaplan MO, eds. Methods in Enzymology. New York, London: Academic Press, 1970: 20–27.
20. 20 Empie MW, Laskowski M. Thermodynamics and kinetics of single residue replacement in avian ovomucoid third domains: effect of inhibitor interactions with serine proteinases. Biochemistry 1982 ; 21: 2274–2284.
21. 21 Patthy L, Smith EL. Identification of functional arginine residues in ribonuclease A and lysosome. J Biol Chem 1975 ; 250: 565–569.
22. 22 Travis J, Salvesen GS. Human plasma proteinase inhibitors. Annu Rev Biochem 1983 ; 52: 655–709.
23. 23 Potempa J, Korzus E, Travis J. The serpin superfamily of proteinase inhibitors: structure, function, and regulation. J Biol Chem 1994 ; 269: 15957–15960.
24. 24 Potempa J, Travis J. Porphyromonas gingivalis proteinases in periodontitis. Acta Biochim Pol 1996 ; 43: 455–456.
25. 25 Kadowaki T, Baba A, Abe N et al. Suppression of pathogenicity of Porphyromonas gingivalis by newly developed gingipain inhibitors. Mol Pharmacol 2004 ; 66: 1599–1606.
26. 26 Imamura T, Matsushita K, Travis J, Potempa J. Inhibition of trypsin‐like cysteine proteinases (gingipains) from Porphyromonas gingivalis by tetracycline and its analogues. Antimicrob Agents Chemother 2001 ; 45: 2871–2876.
27. 27 Sasaki SD, Cotrin SS, Carmona AK, Tanaka AS. An unexpected inhibitory activity of Kunitz‐type serine proteinase inhibitor derived from Boophilus microplus trypsin inhibitor on cathepsin L. Biochem Biophys Res Commun 2006 ; 341: 266–272.